DTx Podcast with Eugene Borukhovich Digital Health Today

In this episode we jumped right into the drug+ discussion with Pamela Stahl, Chief Commercial Officer at Sidekick Health.
In their own words Sidekick health is all about “Gamified digital therapeutics built on science, rooted in behavioral economics, and scalable across multiple therapeutic areas.”

In this episode, we cover:

The origin of Sidekick Health and what led Tryggvi to start the company

The funding journey from being a young company in Iceland to today

Patient and health consumer experience

Combining clinical evidence with gamification

The complexities of clinical trials with pharma clients

And much more!


Guest Links and Resources:

Connect with Pamela Stahl on LinkedIn

Visit sidekickhealth.com


Host Links:

Connect with Eugene Borukhovich: Twitter | LinkedIn


Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn


Connect with YourCoach.health: Website | Twitter


Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App


HealthXL: Website | Twitter | Join an Event




Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health

Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram

In this episode we jump back into interviewing some of the early trailblazers and speak with Dennis Wall, Founder of Cognoa.
In their owns words, “Cognoa is a pediatric behavioral health company developing digital diagnostic and therapeutic products with the goals of enabling earlier and more equitable access to care and improving the lives and outcomes of children and families living with behavioral health conditions, starting with autism.”
In this episode, we cover:

The founding story and funding journey of Cognoa

Patient journey for children using Canvas Dx for autism spectrum disorder (ASD) diagnostic and therapeutics

How the diagnosis and treatment interplay works in the context of a autism digital therapeutic

Evidence generation journey

Working flexibly with pediatricians and doctors for distribution

The collaborative care model alongside DTx



Guest Links and Resources:

Connect with Dennis Wall on LinkedIn | Twitter


Visit: cognoa.com

Host Links:

Connect with Eugene Borukhovich: Twitter | LinkedIn


Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn


Connect with YourCoach.health: Website | Twitter


Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App


HealthXL: Website | Twitter | Join an Event




Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health

Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram

In this episode, we take a break from interviewing entrepreneurs and switch gears to get into a head of one of the investors in the industry, Justin Norden.
Justin is a Partner at GSR Ventures where he focuses on early-stage investments in digital health. Prior to GSR Ventures, he was CEO and co-founder of Trustworthy AI which was acquired by Waymo (Google self-driving). He worked on the healthcare team at Apple, co-founded Indicator (an NLP based platform for biopharma decision making), and helped start the Stanford Center for Digital Health.

In this episode, we cover:

The Healthcare Thesis at GSR Ventures

Virtual Reality (VR) Digital Therapeutics

Stand-alone DTx (biotech-like pipelines) vs. Drug+ DTx

What it would take to scale existing Prescription Digital Therapeutics

The Role Of Health Coaching alongside AI automation

The Drivers of Success Going Forward for the Digital Therapeutics Market


Guest Links and Resources:

Connect with Justin Norden on LinkedIn | Twitter

Visit https://gsrventuresglobal.com


Host Links:

Connect with Eugene Borukhovich: Twitter | LinkedIn


Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn


Connect with YourCoach.health: Website | Twitter


Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App


HealthXL: Website | Twitter | Join an Event




Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health

Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Gut-directed hypnotherapy has an ability to retrain both nervous systems to work together to communicate better, giving the central nervous system the ability to downregulate the hyper vigilant signals that are being sent up from the enteric nervous system.

Despite there being over 20 different randomized controlled trials showing that gut directed hypnotherapy has a positive impact on all of the symptoms of for functional GI disorders, experts still don't really know exactly why it works

To learn more about the future of gut-directed hypnotherapy and the role DTx can play, I went straight to Tim Rudolphi, CEO of metaMe Health.

metaMe, in their own words “believe the best medicine may not be medicine at all. By developing innovative prescription digital therapeutics (PDTs) to combat many common chronic conditions, they are putting the power to heal right in the hands of their patients.” starting with gut health.


In this episode, we cover:

The founding story of metaMe Health

The scientific thesis behind gut-directed hypnotherapy

metaMe’s business hypothesis in action: the process of selling prescription digital therapeutic to a doctor

Commercialization of Prescription Digital Therapeutics

Making space for DTx alongside health coaching



Guest Links and Resources:

Connect with Tim Rudolphi on LinkedIn | Twitter


Visit: metamehealth.com



Episode Mentions:

Danny Bern

Brian Dolan

The Lancet

Mahana


Host Links:

Connect with Eugene Borukhovich: Twitter | LinkedIn


Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn


Connect with YourCoach.health: Website | Twitter


Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App


HealthXL: Website | Twitter | Join an Event




Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health

Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Biofourmis is not your typical standalone DTx company! On the heels of a $300M round, Biofourmis has evolved to a full data driven healthcare services organization with a strong foundation of digital therapies driving care decisions.
To learn more about their work and plans for the future, I went straight to Kuldeep Singh Rajput, founder and CEO of Biofourmis.
Biofourmis, in their own words, “utilizes machine learning, integrated technology and an FDA-cleared analytics engine to streamline connections between patients and care teams, leading to better outcomes for all.”
In this episode we cover:

The path from creation to funding

Digital therapeutic companies evolving into virtual care platforms

Kuldeep’s business hypothesis to entrepreneurial journey

Being device agnostic: build vs buy

Patient adoption and utilization

And much more!


Guest Links and Resources:

Connect with Kuldeep Singh on LinkedIn | Twitter


Visit biofourmis.com



Host Links:

Connect with Eugene Borukhovich: Twitter | LinkedIn


Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn


Connect with YourCoach.health: Website | Twitter


Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App


HealthXL: Website | Twitter | Join an Event




Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health

Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram

Cognitive behavioral therapy (CBT) is an evidence-based form of therapy that has been in use for decades. My guest in this episode believes that CBT can be applied to create better therapeutics, and, in fact, that's exactly what his company is called: Better Therapeutics.

Dr. Mark Berman, the Chief Medical Officer at Better Therapeutics, explained that the goal of CBT is to "help people change some of those core beliefs, which then directly influence what we do on a day to day basis."

And while CBT was originally applied to help people with conditions like PTSD, anxiety and depression, the team at Better Therapeutics have developed their own variant of CBT to apply the core principles of CBT to the ideas that drive root behaviors like diet, exercise and other supportive lifestyle behaviors.

Tune into this episode to hear how Better Therapeutics are creating new digital treatments to reverse the progression of cardiometabolic disease, improve quality of life and inform clinical decisions.

In this episode, we cover:

Patient experience using digital therapeutics for type 2 diabetes

Nutritional CBT - Better Therapeutics innovative new form of Cognitive Behavioral Therapy

Why companies are opting to create Prescription Digital Therapies rather than self-managed lifestyle apps

What’s next in the Better Therapeutics pipeline and how these decisions are made

The future of Digital Therapeutic infrastructure


Guest Links and Resources:

Connect with Mark Berman on LinkedIn | Twitter


Visit bettertx.com



Episode Mentions:

Kevin Appelbaum - founder of Better TX: LinkedIn


Margaret Moore - Founder & CEO Wellcoaches Corporation: LinkedIn



Host Links:

Connect with Eugene Borukhovich: Twitter | LinkedIn


Connect with Chandana Fitzgerald, MD: Twitter | LinkedIn


Connect with YourCoach.health: Website | Twitter


Check out Shot of Digital Health with Eugene and Jim Joyce: Website | Podcast App


HealthXL: Website | Twitter | Join an Event




Season 2 of Digital Therapeutics Podcast would not be possible without the support of leading DTx organizations. Thank you to:
> Presenting Partner: Amalgam Rx
> Contributing Sponsors: Akili | Big Health | Click Therapeutics | Lindus Health

Follow Digital Health Today:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram

Follow Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram